Super User
New WHO data on co-administration of treatment for drug-resistant tuberculosis and hepatitis C
The expert evidence indicated that co-administering MDR-TB and HCV treatments, as compared to delaying HCV treatment while treating MDR-TB alone, may yield several benefits.
Co-administration of treatment for drug-resistant tuberculosis and hepatitis C: rapid communication
World Health Organization, 2024 Mar (EN)
Bromberg DJ, Galvez de Leon SJ, Litz T, Azbel L, Liberman AR, Polonsky M, Dvoriak S, Saichuk N, Taxman F, Altice FL.
PLOS Glob Public Health. 2023, Nov 1 (EN)
Carroll JJ, Rossi SL, Vetrova MV, Blokhina E, Sereda Y, Lioznov D, Luoma J, Kiriazova T, Lunze K.
Int J Drug Policy. 2023 Jul (EN)
Community-based HIV prevention services for transgender people in Ukraine: current situation and potential for improvement
Neduzhko O, Saliuk T, Kovtun O, Semchuk N, Varetska O.
BMC Health Serv Res. 2023, Jun 14 (EN)
Dumchev K, Guo X, Ha TV, Djoerban Z, Zeziulin O, Go VF, Sarasvita R, Metzger DS, Latkin CA, et al.
BMC Infect Dis. 2023, May 11 (EN)
An acceptance-based, intersectional stigma coping intervention for people with HIV who inject drugs-a randomized clinical trial
Luoma JB, Rossi SL, Sereda Y, Pavlov N, Toussova O, Vetrova M, Bendiks S, Kiriazova T, Krupitsky E, Lioznov D, Blokhina E, Lodi S, Lunze K.
Lancet Reg Health Eur. 2023 Mar (EN)
The Relationship Between Intersectional Drug Use and HIV Stigma and HIV Care Engagement Among Women Living with HIV in Ukraine
Owczarzak J, Fuller S, Coyle C, Davey-Rothwell M, Kiriazova T, Tobin K.
AIDS Behav. 2023 (EN)
The Global Fund: Ukraine Progress Assessment
The full-scale invasion of russia in February 2022 had a profound impact on various aspects of life in Ukraine, including healthcare and the fight against HIV and tuberculosis. The Global Fund conducted an assessment of the situation in Ukraine from the moment of the full-scale invasion until the beginning of 2023.
Ukraine Progress Assessment
The Global Fund, 2023 Desember (EN)